Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 2/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | TARS1 | P26639 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.31 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30950292 | 0.87 | TARS1 (0.37) | TARS1DOT1L | |
| SCHEMBL29413061 | 0.86 | HTR2B (0.35) | HTR2BHTR2CADORA3ADRA2BHTR2A | |
| SCHEMBL26090156 | 0.86 | HTR2B (0.35) | HTR2BHTR2CADORA3ADRA2BHTR2A | |
| SCHEMBL28433831 | 0.82 | HTR2C (0.33) | HTR2BHTR2C | |
| SCHEMBL28894183 | 0.78 | ADORA3 (0.54) | ADORA3KDM4EPKM | |
| SCHEMBL28894185 | 0.78 | ADORA3 (0.54) | ADORA3KDM4EPKM | |
| SCHEMBL29089525 | 0.74 | TARS1 (0.39) | TARS1 | |
| SCHEMBL27721224 | 0.74 | HTR2B (0.34) | HTR2BHTR2CADORA3ADRA2BHTR2A | |
| SCHEMBL28662239 | 0.73 | ADORA2A (0.38) | — | |
| SCHEMBL1274809 | 0.73 | ADORA3 (0.51) | ADORA3KDM4EPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118251494-A | Compositions and methods for modulating KRAS expression | 美国微哲默理有限责任公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118176299-A | Compositions and methods for modulating NLRP3 or NLRP1 expression | 美国微哲默理有限责任公司 | 2024-06-11 | — | — | CN | disclosed |